Clinical Trials in France / NCT07243236
Recruiting
Observational
Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations
NCT07243236 · tracked via the Priya Life Science France tracker
Condition(s) studied
Healthcare ProvidersPostpartum
Investigational drug(s) / intervention(s)
Questionnaires for patientsQuestionnaires for healthcare providers
Questionnaires for patients: Questionnaires for patients
Questionnaires for healthcare providers: Questionnaires for healthcare providers
Study summary
The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).
Eligibility
Inclusion Criteria:
For patients:
1. For the assessment of pneumococcal coverage among patients eligible for this vaccination:
* Individuals aged 18 years or older,
* Individuals followed in outpatient consultations within a department and healthcare institution participating in the project;
* Individuals eligible for pneumococcal vaccination against according to current French recommendations,
* Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME).
2. For the assessment of pertussis vaccination among pregnant women:
* Women aged 18 years or older,
* Women who have had at least one follow-up outpatient consultation from 20 weeks of gestation in a maternity ward participating in the project,
* Women in the immediate postpartum period (during their maternity stay) who have given birth to one or more live children and delivered after 36 weeks of gestation,
* Women who have declared their pregnancy and are covered under maternity insurance (i.e., from the first day of the sixth month of pregnancy until the 12th day after delivery).
For healthcare professionals: all vaccinating healthcare providers working in a participating department or center.
Exclusion Criteria:
* Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).
Primary outcome measure(s)
- Number of subjects vaccinated against pneumococcal infections — Month 3
Variation in the number of subjects vaccinated against pneumococcal infections (eligible subjects according to current recommendations) before (according to the usual intra-hospital organization) and after the implementation of the National Health Insurance funding for vaccines made available during outpatient consultations for the target populations across four healthcare institutions in the Ile-de-France region - Number of subjects vaccinated against pneumococcal infections — Month 18
Number of subjects vaccinated against pneumococcal infections (eligible subjects according to current recommendations), before (according to the usual intra-hospital organization) the implementation of the National Health Insurance funding for vaccines made available during outpatient consultations for the target populations - Number of subjects vaccinated against pertussis — Month 3
Variation in the number of subjects vaccinated against pertussis during pregnancy, before (according to the usual intra-hospital organization) and after the implementation of the National Health Insurance funding for vaccines made available during outpatient consultations for the target populations - Number of subjects vaccinated against pertussis — Month 18
Variation in the number of subjects vaccinated against pertussis during pregnancy, before (according to the usual intra-hospital organization) and after the implementation of the National Health Insurance funding for vaccines made available during outpatient consultations for the target populations
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| COCHIN HOSPITAL - Assistance Publique-Hôpitaux de Paris (APHP) | Paris | IDF | Recruiting |
| Sud Seine Et Marne Hospital | Fontainebleau | France | Not Yet Recruiting |
| Sud Seine Et Marne Hospital | Montereau-Fault-Yonne | France | Not Yet Recruiting |
| Sud Seine Et Marne Hospital | Nemours | France | Not Yet Recruiting |
| Rambouillet Hospital | Rambouillet | France | Not Yet Recruiting |
| Delafontaine Hospital | Saint-Denis | France | Not Yet Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07243236 on ClinicalTrials.gov ↗ ← All trials in France